Brook Venture Partners

About

Building Market Leaders: Brook Venture provides capital to expansion stage businesses. More than just investors, we are hands-on partners in success with decades of investment and business experience.

Story

Since 1995, Brook Venture Partners has invested in or acquired controlling interest in over 40 expansion stage companies in the Northeastern and Mid-Atlantic US. We are focused on profitable companies in the Information Technology and Healthcare IT sectors, with initial investments typically under $10 million.

We are currently investing from both Brook Venture Fund II, a $100 million fund, and Brook Partner Fund III which is focused on acquisitions and majority investments.

Brook II’s investors include family offices and institutional investors such as TD Bank, State Street Bank, Merrill Lynch and states including Pennsylvania, Vermont and Maine.

We provide financing to profitable, expansion stage companies. Investment dollars are targeted to support the accelerated business development and sales growth of portfolio companies – effectively scaling an already proven model to help these companies capitalize on their respective market opportunities. We act as lead investor and play an active role in building strong, outside-dominated boards where investors and industry experts add significant value. Our team is highly focused on sales & marketing acceleration and works with the portfolio companies to maximize lead generation, sales conversion rates and overall sales and marketing activity. Beginning at the time of investment Brook works with management teams to build portfolio companies toward exit.

Mission

Our mission is to invest capital in high-growth, profitable, expansion-stage companies, primarily within the Information Technology and Healthcare IT fields. Our objective is to realize venture level returns without assuming venture level risk.

We are prudent investors focused on reoccurring revenue businesses where the level of risk is deemed low in proportion to the return profile. Brook seeks high rewards for its capital, but we share the upside with management through unique incentives that reward management for growth and capital appreciation.

Brook focuses on initial investments typically under $5 million, an inefficient market sector where we have established a track record and deal flow.

Products

Brook Fund I: Brook I invested in a total of 18 companies. Brook’s investment model performed well even through the difficult 1998-2002 period. The IRR for Brook Fund I and related co-investments places Brook I in the top quartile of same vintage year funds. Brook I is fully invested and has successfully sold the majority of its portfolio companies.

Brook Fund II: Brook II is an SBIC fund licensed by the US Small Business Administration. Brook II is a $100 million fund and has invested in 17 companies to date. Brook II investments are typically $5-$10 million per company with a continued focus on the information technology and healthcare IT sectors in the Northeast.

Brook Partner Fund I: Partner Fund I invested in 10 companies in the information and medical technology sectors in the Northeast. The last investment was made in 2004 and the results place this fund in the top quartile of comparable funds nationally.

Brook Partner Fund II: Partner Fund II invested in 10 companies in the information and medical technology sectors in the Northeast. The most recent investment was made in 2011. 6 of the 10 companies remain active in the fund today.

Brook Partner Fund III: Partner Fund III has invested in 3 companies to date and is active, making additional acquisitions and control investments in the information technology and healthcare IT sectors.